找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Clinician’s Manual: Treatment of Hypertension; Third Edition Franz H Messerli Book 2011Latest edition Springer Healthcare Ltd. 2011 Clinica

[復(fù)制鏈接]
樓主: intern
31#
發(fā)表于 2025-3-26 21:02:14 | 只看該作者
32#
發(fā)表于 2025-3-27 04:45:49 | 只看該作者
ce..Includes dozens of clear and informative tables and figures to maximize comprehension..Addresses the most recent?and crucial developments in a very common chronic condition..Gives a comprehensive review of currently available medications and combination therapy..Approximately one billion people
33#
發(fā)表于 2025-3-27 08:26:19 | 只看該作者
Conclusion: The Miscellarian Race, same dose of the same drug or combination, despite the fact that BP is not at goal. Any excuses volunteered by the patient (ie, crowded parking garage, mother-in-law visiting) seem good enough to rationalize that day’s high BP as an exception and delay further therapeutic intervention.
34#
發(fā)表于 2025-3-27 12:52:28 | 只看該作者
35#
發(fā)表于 2025-3-27 16:27:04 | 只看該作者
36#
發(fā)表于 2025-3-27 19:49:54 | 只看該作者
Fashions and fads,ngual application is of no added benefit because what gets into the blood stream is actually what is swallowed. Also, sublingual nifedipine lowers BP in a completely uncontrolled way, and such an abrupt BP drop has been associated with acute MI, stroke and death. Clearly, this is BP cosmetics and should be considered malpractice.
37#
發(fā)表于 2025-3-27 22:32:13 | 只看該作者
38#
發(fā)表于 2025-3-28 05:29:45 | 只看該作者
Evidence-based versus eminence-based therapy,that out of 100 screened patients with isolated systolic hypertension only one was included in the SHEP study and 99 were excluded for one reason or another. Can the evidence derived from 1% of the population be extrapolated to the remaining 99%?
39#
發(fā)表于 2025-3-28 10:14:13 | 只看該作者
https://doi.org/10.1007/978-1-907673-32-0Clinical; Professional; Reference; Cardiology
40#
發(fā)表于 2025-3-28 13:15:21 | 只看該作者
978-1-907673-08-5Springer Healthcare Ltd. 2011
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 04:35
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
吴旗县| 永丰县| 舟山市| 井冈山市| 什邡市| 南川市| 石台县| 吉林市| 洞口县| 高台县| 苍山县| 延安市| 朝阳市| 新宁县| 昌邑市| 锦屏县| 西宁市| 东乌| 云林县| 东光县| 金山区| 桐城市| 宁国市| 柏乡县| 呼伦贝尔市| 股票| 花莲县| 资中县| 辰溪县| 南陵县| 交口县| 襄汾县| 彰化县| 田阳县| 临朐县| 尖扎县| 阳新县| 高雄县| 昌图县| 永州市| 凤山市|